Medifast (NYSE:MED) Posts Quarterly Earnings Results, Beats Expectations By $0.26 EPS

Medifast (NYSE:MED) released its earnings results on Tuesday. The specialty retailer reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.16) by $0.26, Zacks reports. The firm had revenue of $119.00 million for the quarter, compared to the consensus estimate of $114.25 million. Medifast had a return on equity of 10.66% and a net margin of 0.35%. Medifast updated its Q1 2025 guidance to -0.500-0.000 EPS.

Medifast Stock Performance

Medifast stock traded down $0.10 during midday trading on Thursday, hitting $14.20. 66,730 shares of the company were exchanged, compared to its average volume of 221,969. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.55 and a current ratio of 3.11. Medifast has a fifty-two week low of $13.57 and a fifty-two week high of $44.72. The business has a fifty day simple moving average of $16.36 and a two-hundred day simple moving average of $17.99. The firm has a market capitalization of $155.29 million, a PE ratio of 78.94 and a beta of 1.14.

Analyst Upgrades and Downgrades

Separately, DA Davidson decreased their price objective on shares of Medifast from $17.00 to $16.50 and set a “neutral” rating for the company in a research note on Wednesday.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.